5.0 based on 2 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Guenther Koehne, M.D., Ph.D., is chief of Bone Marrow Transplantation and Hematologic Oncology at Miami Cancer Institute, a world-class cancer center, part of Baptist Health South Florida and member of the Memorial Sloan Kettering Cancer Alliance. He oversees the implementation of standard operating procedures, treatment protocols and clinical trials for bone marrow transplantation at the Institute in close collaboration with colleagues at Memorial Sloan Kettering Cancer Center. Dr. Koehne is an internationally recognized expert in the treatment of leukemia, myelodysplastic syndrome, multiple myeloma and other lymphoproliferative diseases, both with autologous and allogeneic stem cell transplantations. He is renowned for his work in adoptive immunotherapeutic approaches with antigen-specific, donor-derived T lymphocytes in the treatment of viral complications following allogeneic transplants and for developing new approaches in the treatment of patients with high-risk multiple myeloma, minimal residual disease of leukemia and relapsed disease post-allogeneic bone marrow transplantation. A physician-scientist, Dr. Koehne has served as the principal investigator or principal co-investigator of numerous clinical trials involving bone marrow transplantation, particularly in multiple myeloma. Dr. Koehne is Board certified in internal medicine and medical oncology. He received his medical degree and Ph.D. from Medical University of Hamburg, Germany, where he also completed a residency in internal medicine. He completed an additional internal medicine residency at Rush University Medical Center in Chicago. He completed a medical oncology/hematology fellowship at Memorial Sloan Kettering Cancer Center in New York, N.Y., and an additional research fellowship in the Immunology Program at the Sloan Kettering Institute for Cancer Research, Allogeneic Bone Marrow Transplantation Service, where he also served as a research associate.